Web Analytics
RDHL (NASDAQ) Stock Analysis | REDHILL BIOPHARMA LTD – Deepscope
MARKET

Select Market Data Region

RDHL — REDHILL BIOPHARMA LTD (Healthcare >> Drug Manufacturers - Specialty & Generic)

RDHL FAQ

What is RDHL's ROE?

REDHILL BIOPHARMA LTD reports a Return on Equity (ROE) of -193.70%.

What is RDHL's dividend yield?

REDHILL BIOPHARMA LTD offers a dividend yield of 0.00%.

What is RDHL's Deepscope Quality Score?

Deepscope rates RDHL's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy RDHL?

Deepscope's AI Timing Score for RDHL is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does RDHL belong to?

REDHILL BIOPHARMA LTD is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-03 | FS: 2026-03-31)

RDHL

REDHILL BIOPHARMA LTD
USD 1.00
-0.01 (-0.99%) Day Change
0.04
D/E
-193.7%
ROE
-32.6%
ROA
0.00%
Div Yield

REDHILL BIOPHARMA LTD
TYPE: STOCK
MARKET: NASDAQ

Compare   Watchlist   Myport
USD 1.00
Price
-0.01 (-0.99%)
Day Change
NEWS SCORE: 73

RDHL, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...

38

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROE is relatively low.
ROA is relatively low.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors 50%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 73
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 1.00
  PBV / Sector
1.23 / 2.65
GOOD
  Earning Per Share -1.58
  PE / Sector
N/A / 22.64
  PEG or PE/Growth / Sector
N/A / 0.11
  Average 1M Daily Value
0.10 M
GREAT
  Average 1W Daily Value
0.08 M
GREAT
Timing Factors 42%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 41%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 56%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-102.06 / 15.98
  NPM Average (%) / Sector
-20.91 / -16.38
  NPM Change Average (%) / Sector
-132.48 / 113.39
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-32.62 / 8.16
  ROA Average (%) / Sector
-4.30 / 2.38
  ROA Change Average (%) / Sector
314.14 / 108.63
GREAT
  ROE (%) / Sector
-193.70 / -0.19
  ROE Average (%) / Sector
255.36 / 7.40
GREAT
  ROE Change Average (%) / Sector
579.31 / 371.95
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 4%
X
  Dividend (%) / Sector
N/A / 0.54
  Dividend Average (%) / Sector
N/A / 3.08
  Dividend Change Average (%) / Sector
N/A / 15.11
Registration Details
X
  Analyze Date 2026-06-04 09:24:22
  Symbol RDHL
  Name REDHILL BIOPHARMA LTD
  Sector Healthcare >> Drug Manufacturers - Specialty & Generic
  Market NASDAQ
  Listed Shares 5.19 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 5.24 / 9,480.84
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 21 Ha?arba?a Street, Tel Aviv-Yafo, Israel, 6473921

Phone: 972 3 541 3131

Website: https://www.redhillbio.com

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 that is in Phase 3 clinical trial for the treatment of pulmonary Mycobacterium avium complex disease in adults. The company was incorporated in 2009 and is headquartered in Tel Aviv-Yafo, Israel.

ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic

RDHL (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
RDHL
RDHL
USD 1.00 (-0.99%)
+ Watch + Port Chart